| Features | |
| Active substance | Peptide |
| Blood pressure | Can increase blood pressure, particularly at higher doses |
| Chemical name | 17-beta-hydroxyandrost-4-en-3-one |
| Dosage (medical) | 50-400 mg every 2-4 weeks (as intramuscular injection) |
| Dosage (sports) | 250-1000 mg per week (as intramuscular injection) |
| Effects | Increased muscle mass and strength, improved recovery, enhanced red blood cell production |
| Formula | C19H28O2 |
| Half-life | Approximately 8-12 hours in injectable form (varies by ester) |
| Hepatotoxicity | Low in injectable form but can be moderate to high in oral form |
| Lab Test | Testosterone levels can be measured in the blood |
| Main action | Increases protein synthesis and muscle mass, decreases fat deposition, and enhances recovery |
| Side effects | Acne, hair loss, liver damage, cardiovascular issues, hormonal imbalances, mood swings |
| Storage conditions | Store at room temperature away from light and moisture |
| Substance class | Androgen |
| Trade name | Delatestryl, Depo-Testosterone, AndroGel, among others |
| Use in sports | Commonly used in bodybuilding and strength sports to enhance muscle mass and performance |
| Water Retention | Yes, can cause significant water retention leading to a puffy appearance |
| Active ingredient, mg | 2 |
| Release form | Vial |
| Manufacturer | Omstal Pharma |
| Packing | Vial |